MACDONALD, Alexander S. http://orcid.org/0000-0001-6530-9058
MCCONNACHIE, Alex
DICKIE, David Alexander
BATH, Philip M.
FORBES, Kirsten
QUINN, Terence http://orcid.org/0000-0003-1401-0181
BROOMFIELD, Niall M.
DANI, Krishna
DONEY, Alex
MUIR, Keith W.
STRUTHERS, Allan
WALTERS, Matthew
BARBER, Mark
BHALLA, Ajay
CAMERON, Alan
GUYLER, Paul
HASSAN, Ahamad
KEARNEY, Mark
KEEGAN, Breffni
LAKSHMANAN, Sekaran
MACLEOD, Mary Joan
RANDALL, Marc http://orcid.org/0000-0002-3196-182X
SHAW, Louise
SUBRAMANIAN, Ganesh
WERRING, David
DAWSON, Jesse http://orcid.org/0000-0001-7532-2475
Funding for this research was provided by:
Stroke Association (TSA BHF 2013/01)
British Heart Foundation (TSA BHF 2013/01)
Article History
Received: 1 October 2023
Revised: 20 February 2024
Accepted: 22 February 2024
First Online: 4 March 2024
Competing interests
: DAD received payment for image analysis in this study. PMB is a Stroke Association Professor of Stroke Medicine and an Emeritus NIHR Senior Investigator. AS holds a patent for the use of xanthine oxidase inhibition for the treatment of angina pectoris. The other authors declare they have no competing interests.
: XILO-FIST was approved by the UK MHRA and NHS Research Ethics Committee (REC number 14/WS/0113).